Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125391632 | 12539163 | 2 | F | 20160321 | 20160722 | 20160708 | 20160729 | EXP | JP-ROCHE-1789519 | ROCHE | 74.06 | YR | M | Y | 63.00000 | KG | 20160729 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125391632 | 12539163 | 1 | PS | LUCENTIS | RANIBIZUMAB | 1 | Other | IN THE RIGHT EYE 11ML | 11 | ML | Y | 125156 | .05 | ML | SOLUTION FOR INJECTION | QD | |||
| 125391632 | 12539163 | 2 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | IN THE RIGHT EYE | 11 | ML | Y | 125156 | .05 | ML | SOLUTION FOR INJECTION | QD | |||
| 125391632 | 12539163 | 3 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | IN THE RIGHT EYE | 11 | ML | Y | 125156 | .05 | ML | SOLUTION FOR INJECTION | QD | |||
| 125391632 | 12539163 | 4 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | IN THE RIGHT EYE | 11 | ML | Y | 125156 | .05 | ML | SOLUTION FOR INJECTION | QD | |||
| 125391632 | 12539163 | 5 | C | EYLEA | AFLIBERCEPT | 1 | Intraocular | Y | 0 | .05 | ML | QD | |||||||
| 125391632 | 12539163 | 6 | C | LYRICA | PREGABALIN | 1 | Oral | U | 0 | 75 | MG | CAPSULE | BID | ||||||
| 125391632 | 12539163 | 7 | C | LOXONIN | LOXOPROFEN SODIUM | 1 | Oral | U | 0 | 60 | MG | TABLET | QD | ||||||
| 125391632 | 12539163 | 8 | C | LIMAPROST ALFADEX | LIMAPROST | 1 | Oral | U | 0 | 5 | MG | TABLET | BID | ||||||
| 125391632 | 12539163 | 9 | C | DILTIAZEM. | DILTIAZEM | 1 | Oral | U | 0 | 100 | MG | CAPSULE | QD | ||||||
| 125391632 | 12539163 | 10 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | U | 0 | 100 | MG | QD | |||||||
| 125391632 | 12539163 | 11 | C | SELBEX | TEPRENONE | 1 | Oral | U | 0 | 50 | MG | CAPSULE | QD | ||||||
| 125391632 | 12539163 | 12 | C | MUCOSTA | REBAMIPIDE | 1 | Oral | U | 0 | 50 | MG | TABLET | QD | ||||||
| 125391632 | 12539163 | 13 | C | MECOBALAMIN | METHYLCOBALAMIN | 1 | Oral | U | 0 | 500 | MG | TABLET | QID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125391632 | 12539163 | 1 | Retinal vein occlusion |
| 125391632 | 12539163 | 5 | Retinal vein occlusion |
| 125391632 | 12539163 | 6 | Product used for unknown indication |
| 125391632 | 12539163 | 7 | Product used for unknown indication |
| 125391632 | 12539163 | 8 | Product used for unknown indication |
| 125391632 | 12539163 | 9 | Product used for unknown indication |
| 125391632 | 12539163 | 10 | Product used for unknown indication |
| 125391632 | 12539163 | 11 | Product used for unknown indication |
| 125391632 | 12539163 | 12 | Product used for unknown indication |
| 125391632 | 12539163 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125391632 | 12539163 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125391632 | 12539163 | Myocardial infarction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125391632 | 12539163 | 1 | 20150625 | 0 | ||
| 125391632 | 12539163 | 2 | 20150730 | 0 | ||
| 125391632 | 12539163 | 3 | 20151222 | 0 | ||
| 125391632 | 12539163 | 4 | 20160204 | 20160204 | 0 | |
| 125391632 | 12539163 | 5 | 20150903 | 0 |